NovaBridge Biosciences NBP
NASDAQ NBP
$1.30 -0.07 (-4.74%)
As of: Oct 22, 2026 · 11:15 AM EDT

NovaBridge Biosciences (NBP) Convertible Debt (2018 - 2020)

Updated

NovaBridge Biosciences (NBP) posted Convertible Debt of $9.54 million for Q3 2020, down 2.5% from the prior quarter.

Analysis

NovaBridge Biosciences (NBP) Convertible Debt (2018 - 2020) Analysis & Trends

At the end of FY2019, NovaBridge Biosciences' Convertible Debt came in at $9.8 million, down 3.5% from FY2018.

  • In prior years, NovaBridge Biosciences' Convertible Debt was $10.15 million in FY2018.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,172.56 Bn 1,141.15 Bn 19.71 Bn
2 Johnson & Johnson 637.42 Bn 555.95 Bn 17.26 Bn
3 AbbVie 504.13 Bn 477.24 Bn 12.70 Bn
4 Merck 377.81 Bn 332.19 Bn 12.21 Bn
5 Novartis Ag 304.36 Bn 268.35 Bn 11.24 Bn
6 Astrazeneca 267.51 Bn 241.20 Bn 12.86 Bn
7 Amgen 242.18 Bn 197.58 Bn 7.24 Bn
8 Gilead Sciences 194.29 Bn 168.48 Bn 6.22 Bn
9 Pfizer 172.82 Bn 119.47 Bn 10.94 Bn
10 NovaBridge Biosciences 125.43 Mn -670.14 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2020 9.54 Mn
Jun 30, 2020 9.79 Mn
Dec 31, 2019 9.76 Mn
Dec 31, 2018 9.75 Mn
API Access

NovaBridge Biosciences Convertible Debt API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=convertible-debt&ticker=NBP&period=max&api_key=YOUR_API_KEY